By Emily Field ( June 7, 2022, 7:28 PM EDT) -- The U.S. Food and Drug Administration's Office of Prescription Drug Promotion posted on Monday an "untitled letter" — its third this year — to Althera Pharmaceuticals LLC, objecting to the portrayal of safety information in a professional promotional piece for the cholesterol drug Roszet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.